Detalhe da pesquisa
1.
Identification of key residues involved in mediating the in vivo anti-tumor/anti-endothelial activity of Alphastatin.
J Thromb Haemost
; 5(4): 846-54, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17408413
2.
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy.
Nat Biotechnol
; 15(13): 1373-7, 1997 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9415889
3.
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
Cancer Res
; 59(16): 3998-4003, 1999 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10463598
4.
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
Clin Cancer Res
; 6(3): 765-72, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10741695
5.
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect.
Hum Gene Ther
; 11(2): 285-92, 2000 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-10680842
6.
Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Curr Opin Mol Ther
; 1(4): 480-6, 1999 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11713763
7.
Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
Cancer Chemother Pharmacol
; 40(4): 277-84, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9225945
8.
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial.
Cancer Chemother Pharmacol
; 40(3): 189-201, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9219501
9.
The quantitative determination of Photofrin and Polyhaematoporphyrin in plasma: pitfalls and inaccuracies.
J Photochem Photobiol B
; 27(3): 209-17, 1995 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-7769533
10.
The disposition of allyl isothiocyanate in the rat and mouse.
Food Chem Toxicol
; 35(10-11): 933-43, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9463527
11.
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
Br J Cancer
; 88(10): 1622-30, 2003 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-12771932